Head-to-Head

Abbott Laboratories vs. Aclaris Therapeutics, Inc.

ABT

Abbott Laboratories

$98.16 -1.94%

VS ACRS

Aclaris Therapeutics, Inc.

$3.70 -13.35%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTACRS
Market Cap $173.21 billion $628.54 million

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTACRS
Dividend Yield 2.57% —

ABT and ACRS split the dividend factors evenly.

Risk & Sentiment

ABTACRS
Short Interest 0.57% 2.38%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, ACRS overview, ACRS financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.